1-chloro-3-(1-naphthyloxy)-propan-2-one | 65910-96-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-chloro-3-(1-naphthyloxy)-propan-2-one
• 英文别名: 1-chloro-3-(1-naphthyloxy)-2-propanone；3-chloro-1-(1-naphthyloxy)-2-propanone；1-Chloro-3-naphthalen-1-yloxypropan-2-one
• CAS: 65910-96-5
• 化学式: C₁₃H₁₁ClO₂
• 分子量: 234.682
• InChiKey: HHJQQFQOCSJWIH-UHFFFAOYSA-N

物化性质

• 熔点：
  119-120 °C(Solv: isopropanol (67-63-0))
• 沸点：
  379.8±17.0 °C(Predicted)
• 密度：
  1.241±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-chloro-3-(1-naphthyloxy)-propan-2-one 在 Diplogelasinospora grovesii IMI 171018 cells 作用下， 以 苯 为溶剂， 反应 120.0h， 以99%的产率得到(S)-(+)-1-chloro-3-(1-naphthyloxy)-2-propanol
  参考文献：
  名称：

  Diplogelasinospora grovesii IMI 171018，一种用于立体选择性还原酮的新型全细胞生物催化剂

  摘要：

  筛选了416株（71细菌菌株，45放线菌，59酵母，60担子菌，33海洋真菌和148丝状真菌）以寻找在没有氧化酶活性的情况下表现出还原酶活性的微生物。分离出一种新的微生物，Diplogelasinospora grovesii IMI 171018（一种非病原菌菌株），它在还原环酮方面显示出很高的活性和立体选择性。选择该真菌是由于其对单环和双环酮的选择性以及易于培养的条件，从而易于扩大规模。与传统啤酒酵母相比，格罗夫氏杆菌在还原传统酮方面更活跃。II型（来自Sigma），可以在高酮浓度（<60 mM）存在的情况下工作。为了说明作为微生物醇还原酶底物的羰基化合物的空间和电子性质，已应用比较分子场分析（CoMFA）。CoMFA模型具有高度预测性（q 2 = 0.549），可用于解释和预测可被该微生物还原或无法还原的酮的结构。

  DOI：

  10.1016/j.tetasy.2004.01.034
• 作为产物：
  描述：

  1-氯-3-(1-萘基氧基)丙-2-醇 在 吡啶 、 草酸 、 二甲基亚砜 、 N,N'-二环己基碳二亚胺 、 三氟乙酸 作用下， 生成 1-chloro-3-(1-naphthyloxy)-propan-2-one
  参考文献：
  名称：

  通过生物膜改善递送。26.用于β-肾上腺素阻断剂的新型化学递送系统的设计，合成和药理活性。

  摘要：

  合成了已知的β-受体阻滞剂（普萘洛尔，噻吗洛尔，卡替洛尔）的新型酮肟类似物，并测试了其作为潜在的特定部位化学递送系统的能力。假定水解-还原序列可以在虹膜睫状体中产生活性β-受体阻滞剂。发现这些生物前体中的一些在降低兔眼内压方面具有显着活性。普萘洛尔的酮肟衍生物比其母体β-受体阻滞剂更有效，刺激性也更小。虽然酮肟在静脉注射后也表现出对异丙肾上腺素诱导的心动过速的活性，但口服时它们没有活性。局部给药酮肟肟前体后，在兔眼中发现了普萘洛尔的时间延长且浓度很高。然而，灭活的酮肟显然不会在眼睛中转化为相应的β受体阻滞剂。发现在酮肟的物理化学性质与其转化为氨基醇之间的相关性，进而发现它们的后续活性之间存在相关性。结果表明，至少一些酮肟前体可以用作抗青光眼药物，而没有全身性副作用。

  DOI：

  10.1021/jm00396a015

文献信息

• Effects of molecular modification on hypocholesteremic activity of 1,3-bis(substituted phenoxy)-2-propanones and related derivatives
  作者：Steven D. Wyrick、C. Piantadosi

  DOI：10.1021/jm00202a014

  日期：1978.4

  A series of 1,3-bis(substituted phenoxy)-2-propanones, long-chain ketones, and related derivatives has been synthesized, and it has been found that certain analogues produce significant lowering of serum cholesterol levels in Sprague-Dawley rats. These compounds possess no estrogenic properties and are nontoxic at 10 mg/kg/day. Physical studies on these compounds include an attempt to correlate hypocholesteremic

  已经合成了一系列的1，3-双（取代的苯氧基）-2-丙烷，长链酮和相关的衍生物，并且已经发现某些类似物在Sprague-Dawley大鼠中产生血清胆固醇水平的显着降低。这些化合物不具有雌激素特性，在10 mg / kg / day时无毒。对这些化合物的物理研究包括尝试将降胆固醇活性与化合物的亲脂性，电子和空间位阻联系起来。测量某些衍生物的1-辛醇-H2O分配系数，并计算取代基的pi常数。芳香族取代基的哈米特σ常数从文献中获得。
• Labile derivatives of ketone analogs of
  申请人：University of Florida

  公开号：US05017618A1

  公开（公告）日：1991-05-21

  Compounds having the formula ##STR1## and their pharmaceutically acceptable acid addition salts, wherein --X-- is --O--, --CH.sub.2 -- or --; .dbd.Y is .dbd.O or a derivatized keto group which is hydrolyzable or enzymatically convertible to a keto group; R is alkyl having from 1 to 12 carbon atoms or aralkyl having from 7 to 20 carbon atoms; and Ar is the 3-aromatic or heterocyclic residue of a 1-alkylamino-2-propanol having an aromatic or heterocyclic substituent at the 3-position and having .beta.-adrenergic blocking properties; are useful as .beta.-adrenergic blocking agents and are of particular interest in the treatment of glaucoma or for lowering intraocular pressure.

  具有通式##STR1##的化合物及其药学上可接受的酸加成盐，其中--X--为--O--、--CH.sub.2 --或--；.dbd.Y为.dbd.O或可水解或酶学转化成酮基的衍生化酮基团；R为具有1至12个碳原子的烷基或具有7至20个碳原子的芳烷基；Ar为1-烷基氨基-2-丙醇的3-芳香或杂环残基，该残基在3-位具有芳香或杂环取代基，并具有β-肾上腺素能阻断特性；这些化合物可用作β-肾上腺素能阻断剂，特别适用于治疗青光眼或降低眼内压。
• Preparation of halohydrin β-blocker precursors using yeast-catalysed reduction
  作者：Fernando Martı́nez、Carmen Del Campo、J.V Sinisterra、Emilio F Llama

  DOI：10.1016/s0957-4166(00)00425-0

  日期：2000.12

  The preparation of halohydrin beta -blocker precursors using yeast-catalysed reduction of alpha -haloketones was performed. The influence in the yield and e.e, of several process variables was analysed. The (S)-enantioselectivity observed with Saccharomyces cerevisiae can be changed to (R)-enantioselectivity using methyl vinyl ketone as selective inhibitor (25 mM). Using resting fresh cells better yields and e.e.s are observed than using growing cells. Yarrowia lipolytica 1240 resting cells gave 87% yield of (S)-1-chloro-3(1-naphthyloxy)propan-2-ol (99% e.e.). Pichia mexicana 11105 resting cells gave 85% yield of (R)-1-chloro-3(1-naphthyloxy)propan-2-ol (precursor of propranolol) (95% e.e). The reduction process is applied to other alpha -haloketones, a lower e.e, being obtained the closer the size of the ketone substituents. (C) 2001 Elsevier Science Ltd. All rights reserved.
• Highly stereoselective reduction of haloketones using three new yeasts: application to the synthesis of (S)-adrenergic β-blockers related to propranolol
  作者：Fernando Martı́nez Lagos、Jose D. Carballeira、Jose L. Bermúdez、Emilio Alvarez、Jose V. Sinisterra

  DOI：10.1016/j.tetasy.2004.01.024

  日期：2004.3

  The stereoselective reduction of aryloxy-halo-2-propanones 1 or of 1-chloro-3(phthalimdyl)-propan-2-one 2 using baker's yeast usually displays poor yields and/or ees. Three new yeasts, Saccharomyces bayanus CECT 1317, Yarrowia lipolytica CECT 1240 and Pichia mexicana CECT 1015, were selected after a taxonomical screening looking for microorganisms active in the reduction of ketones. These strains have been used for the highly stereoselective reduction of 1 and 2. This reduction is the key step in the stereoselective synthesis of (S)-adrenergic beta-blockers related to the propranolol structure. P. mexicana (reduction of 1) and S. bayanus (the reduction of 2), gave ees greater than 90%, and yields higher than 85% for the (R)-or (S)-halohydrins, respectively. This process constitutes an efficient alternative to the resolution of halohydrins carried out using lipases and can easily be scaled up. (C) 2004 Elsevier Ltd. All rights reserved.
• Chemoenzymatic synthesis of (S) and (R)-propranolol and sotalol employing one-pot lipase resolution protocol
  作者：Ahmed Kamal、Mahendra Sandbhor、Ahmad Ali Shaik

  DOI：10.1016/j.bmcl.2004.05.084

  日期：2004.9

  Synthesis of both enantiomers of biologically active propranolol and sotalol has been achieved in high optical purity by one-pot reduction of 3 and 7 followed by in situ lipase resolution of the respective chlorohydrins. Pseudomonas cepacia lipase immobilized on ceramic particles (PS-C) provided the chlorohydrin and acetate, which on nucleophilic substitution with isopropyl amine afforded the target amino alcohols in high enantio selectivity under mild reaction conditions. (C) 2004 Elsevier Ltd. All rights reserved.